Table 2.
Variable | Primary outcome group (n = 30) | Event-free group (n = 70) | p-value |
---|---|---|---|
LVOT VTI | 8.0 | 8.5 | 0.039 |
Ejection fraction (%) | 32.3 | 27.4 | 0.169 |
Doppler derived cardiac output (L/min) | 2.29 | 2.44 | 0.217 |
Age, years | 80.1 ± 11.3 | 70.7 ± 15.1 | 0.003 |
NYHA class (% in stage III or IV) | 80% | 48.60% | 0.014 |
Hemoglobin, g/dL | 12.7 ± 1.4 | 13.5 ± 2.2 | 0.030 |
Blood urea nitrogen, g/dL | 33.8 ± 15.4 | 24.1 ± 12.5 | 0.001 |
GFR <60 ml/min | 75.90% | 53.10% | 0.038 |
Pulmonary artery pressure, mmHg | 53.0 ± 16.9 | 45.3 ± 12.6 | 0.019 |
Primary outcome was met in 30 subjects (28 death and 2 LVADs); Event free subjects were those alive at one year of follow up from TTE and without requirement for mechanical circulatory support
Abbrev: GFR glomerular filtration rate, LVOT VTI Left ventricular outflow tract velocity time integral, NYHA New York Heart Association